Cargando...
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Hepatic fibrosis, characterized by excessive accumulation of extracellular matrix (ECM) proteins leading to liver dysfunction, is a growing cause of mortality worldwide. Hepatocellular damage owing to liver injury leads to the release of profibrotic factors from infiltrating inflammatory cells that...
Gardado en:
| Publicado en: | Mediators Inflamm |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5143744/ https://ncbi.nlm.nih.gov/pubmed/27999454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7629724 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|